
-
Greece to spend 25 bn euros in 'drastic' defence overhaul: PM
-
Maresca non-committal over Sancho's future at Chelsea
-
WHO facing $2.5-bn gap even after slashing budget: report
-
Real Madrid coach Ancelotti tells tax trial did not seek to defraud
-
Chinese tourists pine for Taiwan's return as Beijing jets surround island
-
Singapore detains teenage boy allegedly planning to kill Muslims
-
What is the 'Qatargate' scandal roiling Israel?
-
AI coming for anime but Ghibli's Miyazaki irreplaceable, son says
-
Swedish insurer drops $160 mn Tesla stake over labour rights
-
Hunger returns to Gaza as Israeli blockade forces bakeries shut
-
Rubio heads to Europe as transatlantic tensions soar
-
Like 'living in hell': Quake-hit Mandalay monastery clears away rubble
-
'Give me a break': Trump tariffs threaten Japan auto sector
-
US approves $5.58 bn fighter jet sale to Philippines
-
Tsunoda embracing pressure of Red Bull debut at home Japanese GP
-
'Outstanding' Hay shines as New Zealand seal Pakistan ODI series
-
El Salvador's Bukele flaunts 'iron fist' alliance with Trump
-
Stock markets mixed as uncertainty rules ahead of Trump tariffs
-
China probes for key target weak spots with 'paralysing' Taiwan drills
-
'Top Gun' and Batman star Val Kilmer dies aged 65: New York Times
-
US lawmakers seek to rename street for Hong Kong's jailed Jimmy Lai
-
Greece to spend big on 'historic' military shake up
-
Trump faces first electoral setback after Wisconsin Supreme Court vote
-
Hay shines as New Zealand beat Pakistan for ODI series win
-
Israel says expands Gaza offensive to seize 'large areas'
-
Curry drops 52 as Warriors win, Jokic bags career-high 61 in Denver loss
-
South Korea mobilising 'all resources' for violence-free Yoon verdict
-
Myanmar quake victim rescued after 5 days as aid calls grow
-
Real Madrid coach Ancelotti tax fraud trial set to begin
-
Warner showcases 'Superman' reboot, new DiCaprio film
-
'Incredible' Curry scores 52 as Warriors down Grizzlies, Bucks edge Suns
-
Asian markets edge up but uncertainty rules ahead of Trump tariffs
-
Nintendo's megahit Switch console: what to know
-
Nintendo to unveil upgrade to best-selling Switch console
-
China practises hitting key ports, energy sites in Taiwan drills
-
Oil, sand and speed: Saudi gearheads take on towering dunes
-
All eyes on Tsunoda at Japan GP after ruthless Red Bull move
-
'Image whisperers' bring vision to the blind at Red Cross museum
-
Hay shines as New Zealand make 292-8 in Pakistan ODI
-
Other governments 'weaponising' Trump language to attack NGOs: rights groups
-
UK imposes online entry permit on European visitors
-
How a Brazilian chief is staving off Amazon destruction
-
Meme politics: White House embraces aggressive alt-right online culture
-
China launches military drills in Taiwan Strait
-
US senator smashes record with 25-hour anti-Trump speech
-
Brazil binman finds newborn baby on garbage route
-
US senator smashes record with marathon anti-Trump speech
-
Trump advisor Waltz faces new pressure over Gmail usage
-
NHI Announces $63.5 Million Senior Housing Investment
-
Miami Church Covers 100% of Uber Rides to Easter Service-Tips Included

US Supreme Court preserves access to abortion pill -- for now
The US Supreme Court on Friday temporarily preserved access to a widely used abortion pill, freezing rulings by lower courts that would have banned or severely restricted availability of the drug.
Two conservative justices disagreed with the decision in the most significant abortion case to reach the nine-member court since it overturned the constitutional right to the procedure 10 months ago.
In delivering a one-paragraph decision, the court did not comment on the merits of the case brought by anti-abortion groups seeking a ban on the abortion drug, mifepristone.
But their order means that mifepristone, which accounts for more than half of the abortions in the United States, will remain available while the case plays out in an appeals court.
The Justice Department of President Joe Biden had filed an emergency appeal asking the Supreme Court to block the lower court rulings that would have banned or restricted access to mifepristone.
The case stems from a ruling by a US District Court judge in Texas, in a lawsuit brought by a coalition of anti-abortion groups, that would have banned mifepristone, which was approved by the Food and Drug Administration (FDA) in 2000.
An appeals court blocked a ban on the abortion pill, but imposed tough restrictions on access, after which the baton was handed to the Supreme Court, where conservatives wield a 6-3 majority.
The Supreme Court decision effectively freezes the lower court rulings pending an appellate court hearing of an appeal from the Justice Department and mifepristone manufacturer Danco Laboratories.
Arguments in the Louisiana-based US Fifth Circuit Court of Appeals have been scheduled for May 17 and any ruling by the appellate court is likely to eventually reach the Supreme Court.
Reacting to the Supreme Court move, Biden said the lower court decisions "would have undermined FDA's medical judgment and put women's health at risk."
"Mifepristone remains available and approved for safe and effective use while we continue this fight in the courts," Biden said in a statement. "I will continue to fight politically-driven attacks on women's health."
- 'Relieved' -
Abortion rights and civil liberties groups welcomed the Supreme Court decision but warned that the future of mifepristone remains in danger.
"We aren't out of the woods by any means," said Jennifer Dalven, director of the ACLU Reproductive Freedom Project.
"This case, which should have been laughed out of court from the very start, will continue on," Dalven said. "And as this baseless lawsuit shows, extremists will use every trick in the book to try to ban abortion nationwide."
"We are relieved that the Supreme Court has granted this full stay," Tammi Kromenaker, the director of an abortion clinic in Minnesota, told AFP. "This means that medication abortion can continue to be offered to patients who prefer this method for termination of pregnancy."
The anti-abortion group Alliance Defending Freedom noted the Supreme Court decision and said it will "look forward to a final outcome in this case that will hold the FDA accountable."
"The FDA must answer for the damage it has caused to the health of countless women and girls and the rule of law by failing to study how dangerous the chemical abortion drug regimen is," said Erik Baptist, senior counsel of the Alliance Defending Freedom.
Since the Supreme Court overturned the landmark Roe v. Wade ruling that enshrined the constitutional right to abortion for half a century, 13 states have banned abortion and it has been severely restricted in others.
The Justice Department has argued that the initial ruling banning mifepristone by the conservative federal judge in Texas, an appointee of former president Donald Trump, was based on a "deeply misguided assessment" of the pill's safety.
Mifepristone is one component of a two-drug regimen that can be used through the first 10 weeks of pregnancy.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit the procedure -- or ban it outright.
F.Bennett--AMWN